-
Je něco špatně v tomto záznamu ?
Caspase-12 Is Present During Craniofacial Development and Participates in Regulation of Osteogenic Markers
B. Vesela, A. Kratochvilova, E. Svandova, P. Benes, K. Rihova, A. Poliard, E. Matalova,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
- Publikační typ
- časopisecké články MeSH
Caspases are evolutionary conserved proteases traditionally known as participating in apoptosis and inflammation but recently discovered also in association with other processes such as proliferation or differentiation. This investigation focuses on caspase-12, ranked among inflammatory caspases but displaying other, not yet defined functions. A screening analysis pointed to statistically significant (P < 0.001) increase in expression of caspase-12 in a decisive period of mandibular bone formation when the original mesenchymal condensation turns into vascularized bone tissue. Immunofluorescence analysis confirmed the presence of caspase-12 protein in osteoblasts. Therefore, the osteoblastic cell line MC3T3-E1 was challenged to investigate any impact of caspase-12 on the osteogenic pathways. Pharmacological inhibition of caspase-12 in MC3T3-E1 cells caused a statistically significant decrease in expression of some major osteogenic genes, including those for alkaline phosphatase, osteocalcin and Phex. This downregulation was further confirmed by an alkaline phosphatase activity assay and by a siRNA inhibition approach. Altogether, this study demonstrates caspase-12 expression and points to its unknown physiological engagement in bone cells during the course of craniofacial development.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21001964
- 003
- CZ-PrNML
- 005
- 20230510125854.0
- 007
- ta
- 008
- 210105s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fcell.2020.589136 $2 doi
- 035 __
- $a (PubMed)33178702
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Vesela, Barbora $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences, Brno, Czechia.
- 245 10
- $a Caspase-12 Is Present During Craniofacial Development and Participates in Regulation of Osteogenic Markers. / $c B. Vesela, A. Kratochvilova, E. Svandova, P. Benes, K. Rihova, A. Poliard, E. Matalova,
- 520 9_
- $a Caspases are evolutionary conserved proteases traditionally known as participating in apoptosis and inflammation but recently discovered also in association with other processes such as proliferation or differentiation. This investigation focuses on caspase-12, ranked among inflammatory caspases but displaying other, not yet defined functions. A screening analysis pointed to statistically significant (P < 0.001) increase in expression of caspase-12 in a decisive period of mandibular bone formation when the original mesenchymal condensation turns into vascularized bone tissue. Immunofluorescence analysis confirmed the presence of caspase-12 protein in osteoblasts. Therefore, the osteoblastic cell line MC3T3-E1 was challenged to investigate any impact of caspase-12 on the osteogenic pathways. Pharmacological inhibition of caspase-12 in MC3T3-E1 cells caused a statistically significant decrease in expression of some major osteogenic genes, including those for alkaline phosphatase, osteocalcin and Phex. This downregulation was further confirmed by an alkaline phosphatase activity assay and by a siRNA inhibition approach. Altogether, this study demonstrates caspase-12 expression and points to its unknown physiological engagement in bone cells during the course of craniofacial development.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kratochvílová, Adéla $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences, Brno, Czechia. $7 xx0301396
- 700 1_
- $a Svandova, Eva $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences, Brno, Czechia.
- 700 1_
- $a Benes, Petr $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.
- 700 1_
- $a Rihova, Kamila $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.
- 700 1_
- $a Poliard, Anne $u Laboratory of Orofacial Pathologies, Imaging and Biotherapies, UFR Odontology Montrouge, Paris University, Paris, France.
- 700 1_
- $a Matalova, Eva $u Laboratory of Odontogenesis and Osteogenesis, Institute of Animal Physiology and Genetics, Academy of Sciences, Brno, Czechia. Department of Physiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Brno, Czechia.
- 773 0_
- $w MED00186212 $t Frontiers in cell and developmental biology. $x 2296-634X $g Roč. 8, č. - (2020), s. 589136
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33178702 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20230510125849 $b ABA008
- 999 __
- $a ind $b bmc $g 1614093 $s 1122248
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 8 $c - $d 589136 $e 20201015 $i 2296-634X $m Frontiers in cell and developmental biology. $n Front Cell Dev Biol $x MED00186212
- LZP __
- $a Pubmed-20210105